Cargando…
Interleukin-20 is involved in dry eye disease and is a potential therapeutic target
BACKGROUND: Dry eye disease (DED) is a common disease in ophthalmology, affecting millions of people worldwide. Recent studies have shown that inflammation is the core mechanism of DED. IL-20 is a proinflammatory cytokine involved in various inflammatory diseases. Therefore, we aimed to explore the...
Autores principales: | Wang, Hsiao-Hsuan, Chen, Wei-Yu, Huang, Yi-Hsun, Hsu, Sheng-Min, Tsao, Yeou-Ping, Hsu, Yu-Hsiang, Chang, Ming-Shi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178884/ https://www.ncbi.nlm.nih.gov/pubmed/35681232 http://dx.doi.org/10.1186/s12929-022-00821-2 |
Ejemplares similares
-
IL-20 bone diseases involvement and therapeutic target potential
por: Wang, Hsiao-Hsuan, et al.
Publicado: (2018) -
The Therapeutic Effects of a PEDF-Derived Short Peptide on Murine Experimental Dry Eye Involves Suppression of MMP-9 and Inflammation
por: Ho, Tsung-Chuan, et al.
Publicado: (2022) -
Interleukin-20 targets podocytes and is upregulated in experimental murine diabetic nephropathy
por: Hsu, Yu-Hsiang, et al.
Publicado: (2017) -
Integrin αv and Vitronectin Prime Macrophage-Related Inflammation and Contribute the Development of Dry Eye Disease
por: Ho, Tsung-Chuan, et al.
Publicado: (2021) -
IL-20 in Acute Kidney Injury: Role in Pathogenesis and Potential as a Therapeutic Target
por: Lin, Tian-Yu, et al.
Publicado: (2020)